Manufacturer record
Revat Laboratories Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
22 batches manufactured by Revat Laboratories Pvt. Ltd (Andhra Pradesh) were declared Not of Standard Quality between October 2019 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
22 records linked to Revat Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Tablets IP 650 mg | RPCT-221Mfg 2025-12 · Exp 2027-11 | Uniformity of WeightUniformity of weight/content | RDTL, Kurnool, Andhra PradeshState lab | May 2026 |
| Calcium Carbonate Tablets I.P. | RCBT-003Mfg 2024-05 · Exp 2026-04 | DescriptionDescription | DCL, TelanganaState lab | Sep 2025 |
| IRON & FOLIC ACID SYRUP IP | RIFS-209Mfg 2024-04 · Exp 2026-09 | pH and Assay of Folic AcidAssay | CDTL HyderabadCDSCO lab | Jun 2024 |
| Rabeprazole Gastro-Resistant Tablets IP 20 mg | RRZT-019Mfg 2021-12 · Exp 2023-11 | Assay and DescriptionAssay | RDTL GuwahatiState lab | Jan 2023 |
| Rabeprazole Gastro Resistant Tablets IP 20 mg | RRZT-023Mfg 2021-12 · Exp 2023-11 | Assay of Rabeprazole Sodium and DescriptionAssay | RDTL GuwahatiState lab | Jan 2023 |
| Rabeprazole Gastro Resistant Tablets IP 20 mg | RRZT-021Mfg 2021-12 · Exp 2023-11 | Assay of Rabeprazole Sodium and DescriptionAssay | RDTL GuwahatiState lab | Jan 2023 |
| Rabeprazole Gastro Resistant Tablets IP 20 mg | RRZT-016Mfg 2021-12 · Exp 2023-11 | Dissolution (Buffer stage), Assay of Rabeprazole Sodium and DescriptionAssay | RDTL GuwahatiState lab | Dec 2022 |
| Rabeprazole Gastro Resistant Tablets I.P. 20 mg | RRZT-020Mfg 2021-12 · Exp 2023-11 | AssayAssay | RDTL GuwahatiState lab | Sep 2022 |
| ZINC SULPHATE DISPERSIBLE TABLETS I.P. 20mg | RZNT-023Mfg 2021-08 · Exp 2023-07 | Disintegration and Assay Uniformity of weight, Uniformity of dispersionAssay | CDTL HyderabadCDSCO lab | Jul 2022 |
| Rabeprazole Gastro Resistant Tablets IP 20mg. | RRZT-017Mfg 2021-12 · Exp 2023-11 | DescriptionDescription | RDTL GuwahatiState lab | Jul 2022 |
| Rabeprazole Gastro Resistant Tablets IP 20mg. | RRZT-018Mfg 2021-12 · Exp 2023-11 | DescriptionDescription | RDTL GuwahatiState lab | Jul 2022 |
| Rabeprazole Gastro Resistant Tablets IP 20mg. | RRZT-013Mfg 2021-12 · Exp 2023-11 | DescriptionDescription | RDTL GuwahatiState lab | Jul 2022 |
| Rabeprazole Gastro Resistant Tablets IP 20 mg | RRZT-015Mfg 2021-12 · Exp 2023-11 | Description & AssayAssay | RDTL GuwahatiState lab | Jul 2022 |
| Rabeprazole Gastro Resistant Tablets I.P. 20mg | RRZT-014Mfg 2021-12 · Exp 2023-11 | AssayAssay | RDTL GuwahatiState lab | Jul 2022 |
| Cefixime Dispersible Tablets I.P. 100 mg | RCET002Mfg 2022-02 · Exp 2024-01 | AssayAssay | CDL KolkataCDSCO lab | Jul 2022 |
| Rabeprazole Gastro Resistant Tablets IP 20mg. | RRZT-021Mfg 2021-12 · Exp 2023-11 | Description and AssayAssay | RDTL GuwahatiState lab | Jun 2022 |
| Rabeprazole Gastro Resistant Tablets IP 20mg. | RRZT-011Mfg 2021-11 · Exp 2023-10 | Description & AssayAssay | RDTL GuwahatiState lab | Jun 2022 |
| Rabeprazole Gastro Resistant Tablets I.P. 20mg. | RRZT-022Mfg 2021-12 · Exp 2023-11 | Assay and DescriptionAssay | RDTL GuwahatiState lab | Jun 2022 |
| Rabeprazole Gastro Resistant Tablets I.P. 20mg. | RRZT-019Mfg 2021-12 · Exp 2023-11 | Description and AssayAssay | RDTL GuwahatiState lab | Jun 2022 |
| Rabeprazole Gastro Resistant Tablets I.P. 20mg. | RRZT-009Mfg 2021-05 · Exp 2023-04 | DescriptionDescription | RDTL GuwahatiState lab | Jun 2022 |
| Atorvastatin Tablets IP 10 Mg | RLT-005Mfg 2018-11 · Exp 2020-10 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Oct 2019 |
| Albendazole Tablets IP 400 mg | RALB-1841Mfg 2018-06 · Exp 2020-05 | Uniformity of weightUniformity of weight/content | RDTL ChandigarhCDSCO lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.